Icecure Medical Ltd. current report, Q1 FY2022

Business Context and Reporting Period

This Form 6-K filing by Icecure Medical Ltd. is dated January 27, 2022. The report serves to disclose the Notice of Meeting, Proxy Statement, and Proxy Card for the Annual and Special General Meeting of Shareholders scheduled for March 3, 2022. The record date for shareholders entitled to vote is February 3, 2022.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance notice and does not contain financial statements or performance data.

Material Changes

No material financial changes versus a prior comparable period are reported in this filing, as it does not contain financial data.

Guidance, Outlook, and Risks

The filing does not include management commentary on financial guidance, outlook, risks, contingencies, or unusual items. Its sole purpose is to notify shareholders of the upcoming meeting and voting eligibility.

Key Facts for Investors

  • Meeting Date: Annual and Special General Meeting is set for March 3, 2022.
  • Record Date: Shareholders must hold Ordinary Shares as of the close of business on February 3, 2022, to vote.
  • Document Type: This is a procedural filing (Form 6-K) incorporating proxy materials, not a financial report.
  • Signatory: The report was signed by Eyal Shamir, Chief Executive Officer.